NMN for Patients Concerned About Liver Health

Malaysia's NAFLD prevalence is ~30% of adults. Patients with elevated ALT, fatty liver on ultrasound, or chronic hepatitis B/C should approach NMN cautiously. Mechanism is positive - NAD+ supports mitochondrial fatty-acid oxidation - but liver-specific NMN trials are limited. Get baseline ALT/AST/GGT before starting. Recheck at 3 months. Stop if liver enzymes rise. Ensure NMN brand has third-party purity testing - adulterated supplements pose hepatotoxic risk.

Key considerations

• Baseline ALT/AST/GGT
• Re-test at 3 months
• Stop if enzymes rise
• Third-party purity verification
• Hepatologist consultation

Use case guides

• Daily energy + fatigue
• Sleep quality
• Cognitive focus + memory
• Metabolic health (pre-diabetes, insulin sensitivity)
• Athletic recovery + performance
• Weight management + body composition
• Skin aging + photoaging
• Hair thinning + androgenic
• Immune resilience
• Longevity foundation
• Jet lag + travel recovery
• Post-COVID fatigue + long COVID
• Perimenopause + hormonal transition
• Sarcopenia + age-related muscle loss